Cardiovascular disease is the leading cause of death in Singapore, accounting for 30.5% of all deaths in 2024 — roughly 22 people every day.[1] Most of those deaths involve conditions that were developing silently for years before any symptoms appeared. The challenge in cardiovascular medicine has always been identifying risk early enough to act on it.
That is where the relationship between erectile dysfunction and heart health becomes clinically relevant. The research showing an association between the two is now extensive and consistent. But the meaning of that association — what it tells a man about his own risk, and what it should prompt him to do — requires careful reading.
This article explains what the evidence shows, what it does not show, and why the appropriate response to erectile dysfunction in a man who has never had his cardiovascular health assessed is an assessment — not alarm.
Why the two conditions are biologically connected
Blood flow is one of the key factors that contribute to good erectile function — specifically, the ability of blood vessels in the penis to dilate rapidly and hold blood under pressure. That process is regulated by the endothelium, the thin inner lining of blood vessels, which produces nitric oxide to trigger smooth muscle relaxation and vasodilation.
The same endothelial dysfunction that underlies atherosclerosis — the hardening and narrowing of arteries that drives most heart attacks and strokes — also impairs the vascular response required for erection. The two conditions share a common pathophysiology: chronic inflammation, oxidative stress, and progressive damage to the endothelial lining of blood vessels throughout the body.[2]
The key anatomical reason erectile dysfunction often appears first is size. Penile arteries have a diameter of approximately 1 to 2 millimetres. Coronary arteries are 3 to 4 millimetres. The same degree of arterial disease — the same plaque burden, the same endothelial impairment — produces a more significant reduction in blood flow through the smaller vessel. A man’s penile circulation may be meaningfully compromised by early vascular disease at a point when his coronary circulation is still functioning adequately.[3]
The key mechanism: Endothelial dysfunction impairs blood flow in both penile and coronary arteries. Because penile arteries are smaller, the effect appears there first — not because the heart is fine, but because smaller vessels are more vulnerable to early vascular disease.
What the evidence shows — and what it means
The association between erectile dysfunction and cardiovascular disease is now well-established across multiple levels of evidence.
Population-level statistics
A 2021 umbrella review published in BJU International — a review of systematic reviews and meta-analyses — found that men with erectile dysfunction had a 45% higher relative risk of cardiovascular disease overall (RR 1.45, 95% CI 1.36–1.54), a 50% higher relative risk of coronary heart disease (RR 1.50), a 55% higher relative risk of myocardial infarction (RR 1.55), and a 36% higher relative risk of stroke (RR 1.36) compared to men without erectile dysfunction.[4] All-cause mortality was also 25% higher in men with erectile dysfunction than in those without.[4]
These are population-level relative risk figures. They describe what happens, on average, across large groups of men. They do not tell any individual man what his personal risk is, and they do not mean that erectile dysfunction causes heart disease or predicts it with certainty. What they establish is a statistically meaningful, biologically coherent association that warrants clinical attention.
The timing relationship
Longitudinal studies suggest that in men with vasculogenic erectile dysfunction — where the cause is vascular rather than psychological or hormonal — erectile symptoms often precede cardiovascular symptoms by two to five years. [3,5] This is the clinical consequence of the artery size difference described above. A man who develops erectile dysfunction in his mid-40s and attributes it to stress or age may be experiencing the first detectable sign of vascular disease that will not produce chest symptoms for several more years.
This does not mean every man with erectile dysfunction will develop heart disease. It means that in men with vasculogenic erectile dysfunction — particularly those with cardiovascular risk factors such as hypertension, diabetes, dyslipidaemia or smoking — the symptom is clinically informative and should not be dismissed.
What the guidelines say
The Princeton IV Consensus — published in Mayo Clinic Proceedings in September 2024 and representing the most current multidisciplinary expert guidance on the management of erectile dysfunction and cardiovascular disease — takes a deliberately measured position.[6] It states that mounting evidence supports the need for clinicians to treat men with erectile dysfunction as being at cardiovascular risk until proven otherwise, and positions erectile dysfunction as a risk-enhancing factor for silent coronary artery disease — particularly in younger men.[6]
Critically, the Princeton IV Consensus does not say that erectile dysfunction is diagnostic of heart disease. It says it is a risk-enhancing marker — a signal that should prompt assessment of cardiovascular risk, not a finding that confirms pathology. The distinction matters clinically and is the basis for how this information should be used in practice.
Princeton IV actually says: Men presenting with erectile dysfunction should be evaluated for cardiovascular risk. It is a prompt for assessment — not a diagnosis of heart disease.
The evidence supports a conversation about cardiovascular risk — not a conclusion about cardiovascular disease. That conversation is worth having with a doctor who understands both sides of it.
What this does not mean
The research on erectile dysfunction and cardiovascular risk is sometimes presented in ways that overstate the connection. Three clarifications are worth making explicitly.
Erectile dysfunction does not diagnose heart disease
An association at the population level does not translate into a predictive test at the individual level. Many men with erectile dysfunction have healthy cardiovascular systems — particularly those whose erectile dysfunction is primarily psychological, hormonal, or medication-related. The presence of erectile dysfunction is not, by itself, sufficient to conclude that a man has occult coronary artery disease.
What it does is raise the prior probability of cardiovascular risk being present — enough to justify a proper assessment in men who have not had one, but not enough to bypass assessment and reach a conclusion.
Psychological erectile dysfunction carries different implications
The cardiovascular association is most consistently demonstrated in vasculogenic erectile dysfunction — where the underlying cause is vascular. Men whose erectile dysfunction is primarily driven by performance anxiety, relationship factors, depression, or stress do not carry the same cardiovascular signal. Distinguishing the two is part of a proper clinical assessment, not an afterthought.
Not all risk factors are equal
A 45-year-old man with erectile dysfunction, well-controlled blood pressure, no diabetes, normal lipids, who does not smoke and exercises regularly, carries a different cardiovascular risk profile than a 52-year-old man with erectile dysfunction, poorly controlled hypertension, a history of smoking, and elevated LDL. The erectile dysfunction is present in both; its cardiovascular significance is not the same.
If ED is presenting in a man in his 40s or 50s, the window between that signal and a potential cardiovascular event is the most clinically useful period to act. Waiting for symptoms elsewhere is waiting too long.
Why this matters in the Singapore context
Cardiovascular disease is not an abstract risk in Singapore. It is the country’s leading cause of death, and its major drivers — hypertension, diabetes, dyslipidaemia, and overweight — are prevalent in the local population. According to the MOH National Population Health Survey 2023–2024, approximately 9.1% of Singapore residents aged 18 to 74 have diabetes, 33.8% have hypertension, and obesity rates are rising.[7]
The landmark Singapore population-based study on erectile dysfunction found that diabetes mellitus and cardiac disease were among the most significant independent risk factors for ED in local men.[8] These are the same conditions that drive cardiovascular risk. For a Singaporean man in his 40s or 50s with erectile dysfunction who has never had a structured cardiovascular assessment — no fasting lipids, no HbA1c, no blood pressure trend — the symptom is an opportunity, not just a concern.
A 2024 review published in Frontiers in Cardiovascular Medicine by National University Hospital and National University Heart Centre Singapore researchers noted that the prevalence of cardiovascular disease in Singapore has increased by nearly 200% over 30 years, reaching an estimated 386,000 cases by 2021, and that dyslipidaemia affects approximately 48% of Singapore adults.[9] These are not background statistics. They are the clinical context in which a Singaporean man’s erectile dysfunction should be evaluated.
What a cardiovascular assessment in this context actually involves
The Princeton IV Consensus recommends that men presenting with erectile dysfunction and no known cardiovascular disease should undergo cardiovascular risk stratification using validated tools — specifically, calculation of their 10-year atherosclerotic cardiovascular disease (ASCVD) risk — and that for men at low calculated risk, a coronary artery calcium (CAC) score can provide additional stratification.[6]
In practice, a cardiovascular assessment in a man presenting with erectile dysfunction begins with the basic building blocks: blood pressure, fasting lipid profile, fasting glucose and HbA1c, and a careful history of smoking, family history of premature cardiovascular disease, and physical activity. From those inputs, a 10-year risk estimate can be calculated. The result of that calculation — not the presence of erectile dysfunction alone — guides what comes next.
This is not a cardiological referral. It is the metabolic and cardiovascular groundwork that should accompany any erectile dysfunction assessment in a man who has not had it done. Most men in their 40s and 50s have not had it done properly.
The finding of elevated cardiovascular risk does not change the treatment of erectile dysfunction — PDE5 inhibitors remain appropriate in most men, with specific precautions around nitrate use. What it changes is the conversation about the underlying health picture, and the opportunity to intervene on risk factors that, addressed now, improve both erectile function and long-term cardiovascular outcomes.
A cardiovascular risk assessment in a man with ED does not need to start with a cardiologist. It starts with a primary care or men's health consultation that takes both the sexual and vascular history seriously.
The appropriate response
Erectile dysfunction in a man who has never had his cardiovascular health properly assessed is a reason to do that assessment. It is not a reason to panic, and it is not a diagnosis. It is a clinical signal — one that has been consistently supported by research for over two decades, and that the most current international consensus guidelines now explicitly recommend acting on.
The window of opportunity matters. A man whose vascular disease is caught early, before coronary symptoms develop, has more options and better outcomes than one whose first presentation is a cardiac event.
If you have ED and have not had your cardiovascular risk properly assessed, that assessment is worth doing — not because ED means you have heart disease, but because it is one of the clearest signals available that such an assessment should happen. Speak to a doctor who will look at both.
- Singapore Heart Foundation. Heart Disease Statistics. myheart.org.sg.
- Gandaglia G, Briganti A, Jackson G, et al. A systematic review of the association between erectile dysfunction and cardiovascular disease. Eur Urol. 2014;65(5):968–978. PMID: 24011423.
- Vlachopoulos C, et al. Endothelial dysfunction, erectile deficit and cardiovascular disease: an overview of the pathogenetic links. Biomedicines. 2022;10(8):1848. PMC9405076.
- Mostafaei H, Mori K, Hajebrahimi S, Abufaraj M, Karakiewicz PI, Shariat SF. Association of erectile dysfunction and cardiovascular disease: an umbrella review of systematic reviews and meta-analyses. BJU Int. 2021;128(1):3–11. doi:10.1111/bju.15313.
- Inman BA, Sauver JL, Jacobson DJ, et al. A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clin Proc. 2009;84(2):108–113. PMID: 19181644.
- Köhler TS, Kloner RA, Rosen RC, et al. The Princeton IV Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc. 2024;99(9):1500–1517. doi:10.1016/j.mayocp.2024.06.002. PMID: 39115509.
- Ministry of Health Singapore. National Population Health Survey 2023–2024 Report. moh.gov.sg.
- Tan JK, Hong CY, Png DJ, Liew LC, Wong ML. Erectile dysfunction in Singapore: prevalence and its associated factors — a population-based study. Singapore Med J. 2003;44(1):20–6. PMID: 12762559.
- Sia C-H, Simon O, Loh P-H, Poh KK. Atherosclerotic cardiovascular disease landscape in Singapore. Front Cardiovasc Med. 2024;11:1342698. doi:10.3389/fcvm.2024.1342698.